Program Committee
Say “hello” to the ISPOR Europe 2026 Program Committee! ISPOR is excited to work with an amazing group of talented and passionate members dedicated to curating a robust slate of sessions and building an impactful program. It’s through their collaboration with ISPOR that we can deliver a meaningful experience to attendees.
Co-Chairs
Malina Müller, PhD
Head of Health Economics, WifOR Institute, Germany
Head of Health Economics, WifOR Institute, Germany
Sandra Nestler-Parr, PhD
SVP Value & Patient Access, BioCryst Pharmaceuticals, BioCryst Ireland Limited, Ireland
SVP Value & Patient Access, BioCryst Pharmaceuticals, BioCryst Ireland Limited, Ireland
Rasmus Prior Gjesing, MSc
Regional Adviser, Access to Medicines & Health Products (AMP), WHO Europe, Denmark
Regional Adviser, Access to Medicines & Health Products (AMP), WHO Europe, Denmark
Members
Hussain Al-Omar, MSc, PhD
Professor of Pharmacoeconomics and Pharmaceutical Policy, Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Saudi Arabia
Abeer Al Rabayah, PhD
Head, Center for Drug Policy and Technology Assessment, King Hussein Cancer Foundation and Center, Jordan
Bryan Bennett, PhD
Head of Patient Centered Outcomes, Senior Director, Jazz Pharma, United Kingdom
Sandrine Bourguignon, MSc, PhD
Global Market Access and Data Generation Lead, Ziwig, France
Adam Day
Director, Ossomed, United Kingdom
Manuela Deidda
Research Fellow in Health Economics, University of Glasgow, Scotland
Lorna Dunning, MSc, MPH
Associate Director – Technology Appraisals, NICE, United Kingdom
Diána Elmer, MSc, PhD
Senior Lecturer, Institute for Health Insurance, University of Pécs, Hungary
Gihan Hamdy El-sisi
Managing Director, HTA Office (Technology Appraisal), Middle East and North Africa, Egypt
Salah Ghabri, MSc, PhD, HDR
Senior Scientific Referent in Health Economics, Department of Medical Evaluation, French National Authority for Health, France
Anders Gorst-Rasmussen, PhD
Head of Launch Evidence Generation & Orchestration, Novo Nordisk, Denmark
Matt Griffiths, MSc
Value and Access Director, Costello Medical, United Kingdom
Rita Faria
Lead Health Economics, Astellas Pharma Europe Ltd, United Kingdom
Carla Fernández-Barceló, BSc, MPH
HEOR Manager, Novartis, Ireland
Kirk Geale, PhD
CEO and Board Member, Quantify Research & Head of RWE, Athagoras Group, Sweden
Marieke Heisen
Director of Research and Patient Evidence, Patvocates & European Patient Advocacy Institute (EPAI), the Netherlands
Anke-Peggy Holtorf , MBA
Managing Director, Health Outcomes Strategies, Switzerland
Seamus Kent, MSc, PhD
Assistant Professor, Erasmus University Rotterdam, the Netherlands
Irina Kinchin, MSc, PhD
Research Assistant Professor, Trinity College Dublin, Ireland
Katarzyna Kolasa, PhD
Director Digital Health Center, Professor of Health Economics, Kozminski University, Poland
Dawn Lee, MSc MMath
Associate Professor, PenTAG, University of Exeter, United Kingdom
Samuel Llewellyn, MPH
Director, Patient Centered Research, Vitaccess, United Kingdom
Ka Keat Lim, MPharm, MSc, PhD
Lecturer in Health Economics, Queen Mary University of London, United Kingdom
Borislava Mihaylova
Professor of Health Economics, Health Economics and Policy Research Unit, Wolfson Institute of Population Health, Queen Mary University of London, United Kingdom & Senior Health Economist, Health Economics Research Centre, University of Oxford, United Kingdom
Dani Prieo-Alhambra, PhD
Professor of Pharmaco- and Device Epidemiology, University of Oxford, Centre for Statistics in Medicine, NDORMS, United Kingdom
Katja Rudell, BSc, MSc, PhD
Vice President, Kielo Research, United Kingdom
Angela Rylands, PhD, Cpyschol
Global Head - Patient Centered Outcomes, Kyowa Kirin International plc., United Kingdom
Fatima Salih, MSc
Scientific Advisor, NICE, United Kingdom
Marie-Therese Estephan Sawaya, MD
Head of Market Access, GEM and Levant, Abbott EPD, Lebanon
Martin Scott, BSc, MSc
Scientific Director, Numerus, Germany
Sheela Upadhyaya
Life Sciences Consultant - Rare Diseases, Openflex Ltd, United Kingdom
Leonor Varela
Professor, Public Health and Preventive Medicine, University of Santiago de Compostela, Spain
Steffen Wahler, MD
CEO, St. Bernward GmbH, Germany